ArticlePhotochemistry and photobiology2021
Improved Ultraviolet Radiation Film Dosimetry Using OrthoChromic OC-1 Film
Article in Photochemistry and photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Wavelength-dependent DNA damage induced by single wavelengths of UV-C radiation (215 to 255 nm) in a human cornea model.Scientific reports · 2025Article
- Wavelength-Dependent DNA Damage Induced by Single Wavelengths of UVC Light (215 to 255 nm) in a Human Cornea Model.Research square · 2024Article
- Response characterization of radiochromic OC-1 films in photon, electron, and proton beams.Medical physics · 2024Article
- Evaluation of OrthoChromic OC-1 films for photon radiotherapy application.Journal of radiation research · 2023Article
- Ocular and Facial Far-UVC Doses from Ceiling-Mounted 222 nm Far-UVC Fixtures.Photochemistry and photobiology · 2023Article
- No Evidence of Induced Skin Cancer or Other Skin Abnormalities after Long-Term (66 week) Chronic Exposure to 222-nm Far-UVC Radiation.Photochemistry and photobiology · 2023Article
- Wavelength-dependent DNA Photodamage in a 3-D human Skin Model over the Far-UVC and Germicidal UVC Wavelength Ranges from 215 to 255 nm.Photochemistry and photobiology · 2022Article
- Virus inactivation and skin safety studies using far-UVC LEDs.Photochemistry and photobiologyArticle
- Film dosimetry for occupant exposure monitoring within Far-UVC installations.Photochemistry and photobiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
There is growing interest in far-UVC lighting, defined as wavelengths from 200 to 230 nm, because research has demonstrated these wavelengths to be an effective antimicrobial technology while posing a minimal hazard to human health. Far-UVC lighting is now being installed to directly irradiate spaces where humans are present, and it will be important to perform measurements to verify far-UVC lighting installations are operating within widely accepted exposure guidelines. In this work, we explore the use of a commercially available film, known as OrthoChromic OC-1, to measure ultraviolet radiation exposure. The film was tested with a variety of ultraviolet wavelengths and irradiance conditions, and the color change of the film was analyzed for increasing levels of radiant exposure. The film response extended over a dynamic range that was greater than the recommended exposure limits for far-UVC radiation so it can potentially be useful for health hazard monitoring. The spectrum of the incident ultraviolet radiation strongly affected the response of the film; therefore, for accurate measurements we recommend the measured spectrum match the spectrum used for calibration. Overall, dosimetry with this film provides a simple, accurate, and inexpensive method of quantifying ultraviolet radiation exposure that is suitable for far-UVC measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.